ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,311.76
0.12%
Dow Jones
43,914.12
-0.53%
Gold vs US Dollar
2,687.305
0.25%
Brent Oil
73.225
0.02%
Bitcoin
99,306.11
-0.75%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Oncotelic Therapeutics Inc (QB) (OTLC)

  7. Oncotelic Therapeutics Inc (QB) (OTLC) News

Oncotelic Therapeutics (QB) (OTLC)

Oncotelic Therapeutics Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:OTLC
DateTimeSourceHeadlineSymbolCompany
26/11/202416:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OTLCOncotelic Therapeutics Inc (QB)
19/11/202422:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:OTLCOncotelic Therapeutics Inc (QB)
14/11/202422:15Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:OTLCOncotelic Therapeutics Inc (QB)
27/08/202412:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OTLCOncotelic Therapeutics Inc (QB)
14/08/202416:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:OTLCOncotelic Therapeutics Inc (QB)
02/02/202422:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OTLCOncotelic Therapeutics Inc (QB)
30/10/202313:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OTLCOncotelic Therapeutics Inc (QB)
23/08/202314:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OTLCOncotelic Therapeutics Inc (QB)
18/08/202321:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:OTLCOncotelic Therapeutics Inc (QB)
13/07/202313:25Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:OTLCOncotelic Therapeutics Inc (QB)
13/07/202313:15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OTLCOncotelic Therapeutics Inc (QB)
30/06/202313:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
30/06/202313:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OTLCOncotelic Therapeutics Inc (QB)
20/06/202316:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
16/06/202316:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
31/05/202313:39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
19/05/202320:45Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
02/05/202321:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
20/04/202310:04Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:OTLCOncotelic Therapeutics Inc (QB)
14/04/202321:02Edgar (US Regulatory)Annual Report (10-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
03/04/202310:04Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
02/03/202314:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OTLCOncotelic Therapeutics Inc (QB)
07/12/202213:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
25/11/202214:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
18/11/202222:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
14/11/202219:25Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
28/09/202213:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
29/08/202213:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OTLCOncotelic Therapeutics Inc (QB)
22/08/202212:32Edgar (US Regulatory)Quarterly Report (10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
15/08/202218:34Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:OTLCOncotelic Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:OTLC

Your Recent History

LSE
GGP
Greatland Gold
LSE
TW.
Taylor Wimpey
LSE
KOD
Kodal Minerals
LSE
ABF
Associated British Foods
LSE
RS1
Rs
LSE
SBRY
Sainsbury (j)
LSE
ADVT
Advancedadvt
LSE
UPS
LSE
DGE
Diageo
LSE
EPP
Energypathways
LSE
ARCM
Arc Minerals
LSE
PANR
Pantheon Resources
LSE
OCDO
Ocado
LSE
HCM
Hutchmed (china)
LSE
PRTC
Puretech Health
LSE
PAF
Pan African Resources
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved